Patients with luminal (HR+/HER2-) subtype showed a relative low level of cavin3 expression compared with those in other subtypes, but the difference did not reach statistical significance ( Supplementary Table 1 ).
← all excerpts
Cavin3 Suppresses Breast Cancer Metastasis <i>via</i> Inhibiting AKT Pathway.
1
—
—